Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

LakePharma Announces Expansion And New MicroBiomanufacturing Center

By LakePharma, Inc. | February 13, 2018

LakePharma, Inc., a U.S.-based biologics company specializing in antibody and protein engineering, cell line development, and protein production, announced the launch of the LakePharma MicroBiomanufacturing (GMP) Center in Hopkinton, MA.

Located at 35 South Street, the newly-acquired 69,000-square foot building includes laboratory, office space, and infrastructure for GMP manufacturing. LakePharma intends to develop the site to perform GMP biologics manufacturing for Phase 1 clinical trials.

The increased capacity at the site will also support growth in LakePharma’s assay development, bioanalytical, process development, and QC services. The company plans to add approximately 100 positions at the Center by 2020.

“The new facility is ideal for LakePharma as it provides the ability to offer fully integrated contract development and manufacturing organization (CDMO) capabilities,” said Hua Tu, LakePharma’s CEO. “Hopkinton is in close proximity to Cambridge/Boston, where we have a large cluster of clients, and we believe that this facility will increase our ability to serve their product development and manufacturing needs. We will soon be able to provide our clients and partners with the end-to-end services they demand.”

The LakePharma MicroBiomanufacturing Center joins the LakePharma Vector Center in Worcester, MA, the LakePharma Development Center in Hayward, CA, and the LakePharma Antibody Centers in South San Francisco, and Belmont, CA.

The company will retain existing lab operations at the LakePharma Vector Center, located on the Worcester Polytech Institute campus, where he comapnay says it plans to double the size of its molecular biology and cell culture operations this year.

(Source: LakePharma, Inc.)

Related Articles Read More >

Great Point Partners logo.
Great Point Partners acquires majority stake in Eutecma to fuel sustainable cold chain growth
Driving success in fast-paced high-tech pharma construction projects
This is a photo of the Fujifilm Diosynth Biotechnologies plant under construction in Holly Springs, North Carolina.
Fujifilm, Regeneron ink $3B U.S. manufacturing agreement
This is the logo of Johnson & Johnson.
J&J breaks ground on $2B manufacturing facility in North Carolina
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE